Huadong Medicine Co., Ltd (SHE: 000963)

Market Cap	50.26B
Revenue (ttm)	41.20B
Net Income (ttm)	3.10B
Shares Out	1.75B
EPS (ttm)	1.77
PE Ratio	16.23
Forward PE	18.02
Dividend	0.70 (2.44%)
Ex-Dividend Date	May 28, 2024

Volume	3,513,460
Open	29.35
Previous Close	28.72
Day's Range	28.53 - 29.35
52-Week Range	25.96 - 44.39
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Huadong Medicine

Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co., Ltd was founded in 1993 and is headquartered in Hangzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 16,969
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2023, Huadong Medicine's revenue was 40.62 billion, an increase of 7.71% compared to the previous year's 37.71 billion. Earnings were 2.84 billion, an increase of 13.59%.